Prasad Thota
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 12
- Pharmacovigilance and Adverse Drug Reactions 12
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Vivekanandan Kalaiselvan (10 shared papers)Subodh Kumar (8 shared papers)Bikash Medhi (12 shared papers)Hardeep Kaur (7 shared papers)Manisha Prajapat (7 shared papers)Phulen Sarma (8 shared papers)Anusuya Bhattacharyya (4 shared papers)Saurabh Sharma (4 shared papers)
- Journals
- PeerJ (1 paper)Safety Science (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)Dermatologic Therapy (1 paper)Journal of Young Pharmacists (1 paper)
- Partner nations
- IndiaBangladeshThailand
In The Last Decade
Prasad Thota
27 papers receiving 340 citations
Peers
Comparison fields: 5 of 94
- Toxicology 121
- Applied Microbiology and Biotechnology 15
- Geriatrics and Gerontology 20
- Infectious Diseases 89
- Otorhinolaryngology 20
Countries citing papers authored by Prasad Thota
This map shows the geographic impact of Prasad Thota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad Thota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad Thota more than expected).
Fields of papers citing papers by Prasad Thota
This network shows the impact of papers produced by Prasad Thota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad Thota. The network helps show where Prasad Thota may publish in the future.
Co-authors
The 25 scholars most cited alongside Prasad Thota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 70 | |
| 2 | 2021 | 44 | |
| 3 | 2021 | 33 | |
| 4 | 2021 | 29 | |
| 5 | 2023 | 23 | |
| 6 | 2020 | 21 | |
| 7 | 2022 | 20 | |
| 8 | 2019 | 16 | |
| 9 | 2015 | 16 | |
| 10 | 2018 | 14 | |
| 11 | 2014 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2016 | 5 | |
| 19 | A systematic review and meta‐analysis of the relative efficacy and safety of treatment regimens for HIV ‐associated cerebral toxoplasmosis: is trimethoprim‐sulfamethoxazole a real option? | 2017 | 3 |
| 20 | 2024 | 2 |
About Prasad Thota
Prasad Thota is a scholar working on Toxicology, Infectious Diseases, Economics and Econometrics, Computational Theory and Mathematics and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 364 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmaceutical Economics and Policy (5 papers), Computational Drug Discovery Methods (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Nephrotoxicity and Medicinal Plants (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Toxicology (121 citations), Applied Microbiology and Biotechnology (15 citations), Geriatrics and Gerontology (20 citations), Infectious Diseases (89 citations) and Otorhinolaryngology (20 citations). Prasad Thota has collaborated with scholars based in India, Bangladesh and Thailand. Frequent co-authors include Vivekanandan Kalaiselvan, Subodh Kumar, Bikash Medhi, Hardeep Kaur, Manisha Prajapat, Phulen Sarma, Anusuya Bhattacharyya, Saurabh Sharma, Seema Bansal and Pramod Avti. Their work appears in journals such as PeerJ, Safety Science, Therapeutic Innovation & Regulatory Science, Dermatologic Therapy and Journal of Young Pharmacists.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.